Momenta Pharma
(MNTA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Sales | 29,144 | 26,430 | 19,850 | 22,393 | 13,795 |
| Gross Profit | 29,144 | 26,430 | 19,850 | 22,393 | 13,795 |
| Operating Expenses | 47,326 | 48,069 | 44,404 | 51,941 | 44,192 |
| Operating Income | -18,182 | -21,639 | -24,554 | -29,548 | -30,397 |
| Other Income | 638 | 653 | 542 | 384 | 347 |
| Pre-tax Income | -17,544 | -20,986 | -24,012 | -29,164 | -30,050 |
| Net Income Continuous | -17,544 | -20,986 | -24,012 | -29,164 | -30,050 |
| Net Income | $-17,544 | $-20,986 | $-24,012 | $-29,164 | $-30,050 |
| EPS Basic Total Ops | -0.26 | -0.31 | -0.35 | -0.44 | -0.44 |
| EPS Basic Continuous Ops | -0.26 | -0.31 | -0.35 | -0.44 | -0.44 |
| EPS Diluted Total Ops | -0.26 | -0.31 | -0.35 | -0.44 | -0.44 |
| EPS Diluted Continuous Ops | -0.26 | -0.31 | -0.35 | -0.44 | -0.44 |
| EBITDA(a) | $-15,823 | $-18,952 | $-22,110 | $-27,092 | $-27,871 |